CollPlant Biotechnologies (CLGN) Exchange Rate Effect (2018 - 2025)
CollPlant Biotechnologies (CLGN) posted Exchange Rate Effect of -$6000.0 for Q4 2025, up 33.33% on a QoQ basis from -$9000.0 in Q3 2025, and down 110.0% year-over-year from $60000.0 in Q4 2024.
CollPlant Biotechnologies (CLGN) Exchange Rate Effect (2018 - 2025) Analysis & Trends
CollPlant Biotechnologies' Exchange Rate Effect history runs 8 years deep, the most recent figure standing at -$6000.0 for Q4 2025.
- Quarterly Exchange Rate Effect fell 110.0% year-over-year to -$6000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $85000.0 (up 159.86% YoY) and the FY2025 annual result came in at $26000.0, up 118.31% from the prior year.
- Exchange Rate Effect was -$6000.0 for Q4 2025 at CollPlant Biotechnologies, up from -$9000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $199000.0 in Q4 2023 and bottomed at -$969000.0 in Q1 2021.
- A 5-year average of -$479157.9 and a median of -$608000.0 in 2022 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2021 — Exchange Rate Effect soared 138.33% — and 2022, when it plunged 525.17%.
- CollPlant Biotechnologies' Exchange Rate Effect stood at $143000.0 in 2021, then plunged by 525.17% to -$608000.0 in 2022, then surged by 132.73% to $199000.0 in 2023, then tumbled by 69.85% to $60000.0 in 2024, then sank by 110.0% to -$6000.0 in 2025.
- Business Quant data shows CLGN's Exchange Rate Effect at -$6000.0 in Q4 2025, -$9000.0 in Q3 2025, and $40000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 19.32 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -6,000.00 |
| Dec 31, 2025 | -6,000.00 |
| Sep 30, 2025 | -9,000.00 |
| Sep 30, 2025 | -9,000.00 |
| Jun 30, 2025 | 40,000.00 |
| Jun 30, 2025 | 40,000.00 |
| Dec 31, 2024 | 60,000.00 |
| Dec 31, 2024 | 60,000.00 |
| Sep 30, 2024 | 39,000.00 |
| Sep 30, 2024 | 39,000.00 |
| Jun 30, 2024 | -118,000.00 |
| Jun 30, 2024 | -118,000.00 |
| Mar 31, 2024 | -123,000.00 |
| Mar 31, 2024 | -123,000.00 |
| Dec 31, 2023 | 199,000.00 |
| Dec 31, 2023 | 199,000.00 |
| Sep 30, 2023 | -969,000.00 |
| Sep 30, 2023 | -969,000.00 |
| Jun 30, 2023 | -969,000.00 |
| Jun 30, 2023 | -969,000.00 |